NEWS
Cluster's life
24 / 05 / 2012
EDELRIS announces Research Agreement with SANOFI
20 / 03 / 2012
Nexity signs an off-plan sale with SERL@IMMO for the innovation platform acCInov
On March 20, Nexity has signed with the investor SERL @ immo SAS, SERL Group's real estate subsidiary, an off-plan sale for the realization of a ...
15 / 03 / 2012
Fundraising for Adocia of ¤ 27.4 million
14 / 03 / 2012
The economist Philippe Aghion, attended by Gérard Collomb, visits the Infectious Diseases Center
13 / 03 / 2012
Lyonbiopole: an efficient system, in favour of innovation and economic development
Lyonbiopole presents very positive results to the press, showing that the cluster’s goals have been achieved and that the organization and its ...
13 / 03 / 2012
PX’Therapeutics launches a clinical trial on prophylactic vaccine against HIV
PX'Therapeutics is pleased to announce the launch of a Phase 1 clinical trial on a prophylactic vaccine against HIV, entitled "Phase 1, Randomised, ...
13 / 03 / 2012
Vivalis : collaboration agreement and commercial license for the production of an antibody
08 / 03 / 2012
genOway et PhenoPro report a strategic alliance
genOway and PhenoPro, spin off of the Institut Clinique de la Souris, create the most advanced and innovative offer in animal model creation and ...
01 / 03 / 2012
Lyonbiopole meets the Ministers Valérie Pecresse and Laurent Wauquiez in Lyon
Lyonbiopole and the regional winners of "Investments for the Future" program shared with Valérie Pecresse and Laurent Wauquiez...
29 / 02 / 2012
ADOCIA: positive phase IIa clinical results on its fast-acting human insulin, HinsBet®
The first clinical results are confirmed on diabetic patients. The main results of this clinical trial are a rapid reduction of glycemia, an ...
29 / 02 / 2012
Rhenovia Pharma opens first US office
Rhenovia Pharma SAS, a biotechnology company specializing in biosimulation applied to the discovery of new medications to treat brain diseases such ...
02 / 02 / 2012
Alizé Pharma licenses its ASPAREC® to EUSA Pharma
Alizé Pharma II, a drug development company focused on oncology and metabolism and part of the Alizé Pharma group, announced today the signing of a ...
26 / 01 / 2012
Alaxia and Stragen launch partnership to speed up
development of new treatment for cystic fibrosis
Le groupe pharmaceutique suisse Stragen et la start-up lyonnaise Alaxia viennent de sceller les termes d’une collaboration qui va accompagner ...
18 / 01 / 2012
Inserm Transfert Initiative raises ¤ 33,5M : Fonds National d’Amorçage's first investment
18 / 01 / 2012
Launching of the BioX4Clusters European project
The BioX4Clusters project selected in December 2011, by the call for projects "Promoting world-class clusters" by DG Enterprise (European ...
18 / 01 / 2012
Lyonbiopole selected for the CEBR Steering Committee
Lyonbiopole was selected in December 2011 to “seat” at the CEBR – Council of European Bio Regions – Steering Committtee.
10 / 01 / 2012
Sanofi launches an innovative start-up biotechnology company, along with 2 venture capital firms
01 / 01 / 2012
Lyonbiopole’s team wishes you the best for 2012
14 / 12 / 2011
Fill in your profile for 2012 Lyonbiopole’s Directory
12 / 12 / 2011
Synapcell, member of Lyonbiopole, once again turns to NeuroTherapeutics Pharma for its epilepsy drug
12 / 12 / 2011
The modeling platform of The CoSMo Company selected by the consortium Biopredyn
01 / 12 / 2011
Indicia Biotechnology enhances its offering in the assessment of immunogenicity of biologics
27 / 07 / 2011
PX’Therapeutics Licenses RIBOVAX’s SEBVI Technology
This licensing agreement aims to provide PX’Therapeutics with access to Ribovax’s patented SEBVI Technology for the discovery and ...
R&D Projects
09 / 12 / 2011
Project ETICS led by Cytoo selected by ISI Oséo
The project ETICS led by Cytoo is supported by OSEO, the French agency supporting innovation, and will receive ¤7.6 million in funding over 5 years.
Events
16 / 03 / 2012
Lyonbiopole and Eurobiomed get associated for the 1st Edition of « Sepsis Collaborative Day»
The 1st edition of the « Sepsis Collaborative Day » held on March 16, at the French Education Institute in Lyon Gerland.
06 / 12 / 2011
Success for Lyonbiopole's Private Inv¤stment Day
Focus on
22 / 05 / 2012
Advanced Liquid Logic France
The US-based company Advanced Liquid Logic Inc. (ALL) and its French subsidiary Advanced Liquid Logic France (ALL France) market their proprietary ...
25 / 04 / 2012
Focus on IMAXIO
IMAXIO is a biotech company focused on vaccines and genomics. Based in Lyons, it was formed in 2006 by the merger of Diagnogene and Avidis (a ...
29 / 03 / 2012
Fluoptics
Fluoptics developed an innovative device to assist surgeons in cancerous tumors resection.
29 / 02 / 2012
Fab'entech
Located at the heart of LyonBiopôle, Fab’entech can thus benefit from the original environment of excellence of LyonBiopôle, the worldwide ...
17 / 01 / 2012
Kallistem
Kallistem is a young start-up that meets the requirements of modern testicular toxicology and issues of male infertility
14 / 12 / 2011
Focus on CYTOO
CYTOO, founded in 2008, is a distinctive Life Sciences Systems/ Tools enabling company that currently offers a disruptive solution that brings ...
21 / 09 / 2011
EDAP TMS
Since inception in 1979, EDAP TMS has been committed to introducing new and innovative technologies for minimally-invasive treatments of urological ...
